Company: OMQS
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001813
Chunk: 503

Company: OMNIQ Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7
Chunk 503
---
0 million before deducting underwriting discounts and commissions and other offering
expenses payable by the Company and assuming no exercise of the Underwriters’ option to purchase additional shares.

Warrants
and Stock Options

The
valuation assumptions used to determine the fair value of each option and warrant awarded during the year ended December 31, 2023 are
as follows: expected stock price volatility 126.44%, expected term in years 3.25, and risk-free interest rate 4.73%. The estimated fair
value of the warrants were $.55.

There
were no options or warrants awarded during the year ended December 31, 2024.

No
warrants were exercised during the years ended December 31, 2023 or 2024.

The
following table summarizes information about warrants granted during the years ended December 31:

 SCHEDULE OF WARRANTS ACTIVITY

    2024  
    2023 

    Number
    of Warrants  
    Weighted Average
                                            Exercise Price  
    Number
    of Warrants  
    Weighted Average
    Exercise Price 

    Balance,
    beginning of year 
     1,606,734  
    $6.28  
     1,481,734  
    $7.34 
  
    Warrants
    granted 
     -  
     -  
     225,000  
     1.00 
  
    Warrants
    expired 
     (847,500) 
     7.00  
     (100,000) 
     10.00 
  
    Warrants
    exercised 
     -  
     -  
     -  
     - 
  
    Balance,
    end of year 
     759,234  
     7.85  
     1,606,734  
     6.28 
  
    Exercisable
    warrants 
     759,234  
    $5.46  
     1,359,234  
    $7.16 

Outstanding
warrants as of December 31, 2024 are as follows:

 SCHEDULE OF OUTSTANDING WARRANTS

    Range
    of Exercise Prices  
    Weighted Average
    Residual Life Span (in years)  
    Outstanding
    Warrants  
    Weighted